Finance

Lists
CPIX:NASDAQ
Cumberland Pharmaceuticals, Inc.
$7.90
-0.13%
(-0.0100) 1D
Aug 13, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CPIX...
Open
$7.90
High
$8.05
Low
$7.63
Mkt. cap
118.37M
Avg. vol.
124.22K
Volume
81.12K
52-wk high
$8.45
52-wk low
$1.85
EPS
-$0.50
Beta
0.08
Shares outstanding
14.98M
No. of employees
93
Open
$7.90
High
$8.05
Low
$7.63
Mkt. cap
118.37M
Avg. vol.
124.22K
Volume
81.12K
52-wk high
$8.45
52-wk low
$1.85
EPS
-$0.50
Beta
0.08
Shares outstanding
14.98M
No. of employees
93
News stories
From web sources and news partners
About Cumberland Pharmaceuticals, Inc.
CEO-
Employees93
Founded1999
HeadquartersNashville, Tennessee, United States
SectorPharmaceutical industry
Websitecumberlandpharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
Aug 4, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.20 / -
0.00%miss
Revenue / Est. (USD)
166.46K / -
0.00%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
8.29M
13.68M
9.13M
166.46K
Cost of goods sold
988.76K
2.24M
1.93M
-
Cost of revenue
988.76K
2.24M
1.93M
-
Research and development expenses
1.25M
1.55M
1.46M
772.16K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.01M
10.25M
7.62M
2.55M
Operating expense
9.27M
12.81M
10.33M
3.33M
Total operating expenses
10.26M
15.05M
12.26M
3.33M
Operating income
-1.97M
-1.37M
-3.13M
-3.16M
Other non operating income
-
-
-
-
EBT including unusual items
-1.94M
-1.41M
-3.28M
-3.10M
EBT excluding unusual items
-1.94M
-1.41M
-3.14M
-3.10M
Income tax expense
5.67K
23.24K
3.87K
3.87K
Effective tax rate
-0.29%
-1.65%
-0.12%
-0.12%
Other operating expenses
-
-
-
-
Net income
-1.94M
-1.41M
-3.29M
-4.12M
Net profit margin
-23.40%
-10.32%
-36.03%
-2,472.48%
Earnings per share
-
-
-
-
Interest and investment income
131.58K
91.97K
78.03K
60.88K
Interest expense
-109.70K
-112.94K
-85.84K
-724.00
Net interest expenses
21.88K
-20.98K
-7.81K
60.16K
Depreciation and amortization charges
-
-
-
-
EBITDA
-927.46K
-329.31K
-1.85M
-3.12M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps